Chemoinformaics analysis of 9-Hydroxy-3-(hydroxymethyl)furo[3,2-b]naphtho[2,3-d]furan-5,10-dione
Molecular Weight | 284.223 | nRot | 1 |
Heavy Atom Molecular Weight | 276.159 | nRig | 21 |
Exact Molecular Weight | 284.032 | nRing | 4 |
Solubility: LogS | -5.239 | nHRing | 2 |
Solubility: LogP | 2.983 | No. of Aliphatic Rings | 1 |
Acid Count | 0 | No. of Aromatic Rings | 3 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
Atoms Count | 29 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 21 | No. of Aromatic Carbocycles | 1 |
nHetero | 6 | No. of Aromatic Hetero Cycles | 2 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 8 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 15 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 14 |
No. of Oxygen atom | 6 | No. of Arom Bond | 15 |
nHA | 6 | APOL | 35.1963 |
nHD | 2 | BPOL | 13.2337 |
QED | 0.554 |
Synth | 2.964 |
Natural Product Likeliness | 1.197 |
NR-PPAR-gamma | 0.888 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Accepted |
Pgp-inh | 0.584 |
Pgp-sub | 0.006 |
HIA | 0.165 |
CACO-2 | -5.064 |
MDCK | 0.0000159 |
BBB | 0.027 |
PPB | 0.92547 |
VDSS | 0.754 |
FU | 0.0732508 |
CYP1A2-inh | 0.963 |
CYP1A2-sub | 0.109 |
CYP2c19-inh | 0.074 |
CYP2c19-sub | 0.056 |
CYP2c9-inh | 0.653 |
CYP2c9-sub | 0.1 |
CYP2d6-inh | 0.1 |
CYP2d6-sub | 0.218 |
CYP3a4-inh | 0.578 |
CYP3a4-sub | 0.127 |
CL | 10.314 |
T12 | 0.422 |
hERG | 0.001 |
Ames | 0.927 |
ROA | 0.968 |
SkinSen | 0.516 |
Carcinogencity | 0.975 |
EI | 0.043 |
Respiratory | 0.271 |
NR-Aromatase | 0.508 |
Antiviral | Yes |
Prediction | 0.70298 |